OPKO Health, Inc. (OPK)

Market Cap	1.07B
Revenue (ttm)	689.41M
Net Income (ttm)	-39.00M
Shares Out	793.05M
EPS (ttm)	-0.06
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,768,220
Open	1.350
Previous Close	1.360
Day's Range	1.340 - 1.380
52-Week Range	1.210 - 2.035
Beta	1.34
Analysts	Buy
Price Target	2.75 (+103.7%)
Earnings Date	Aug 6, 2025

About OPK

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company’s Diagnostics segment operates BioReference Laboratories that offer laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women’s health, and correctional healthcare to physician offices, clinics, hospitals, employers, ...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: Nov 2, 1995
• Employees: 2,997
• Stock Exchange: NASDAQ
• Ticker Symbol: OPK
• Website: https://www.opko.com

Financial Performance

In 2024, OPKO Health's revenue was $713.14 million, a decrease of -17.41% compared to the previous year's $863.50 million. Losses were -$53.22 million, -71.82% less than in 2023.

Analyst Summary

According to 4 analysts, the average rating for OPK stock is "Buy." The 12-month stock price target is $2.75, which is an increase of 103.70% from the latest price.

Price Target

$2.75

(103.70% upside)

Analyst Consensus: Buy